Participants in the conference include publicly-traded companies as well as companies that, like OncoCyte, are not yet publicly traded. During the symposium, may provide an update on the clinical development of OncoCyte's PanC-DxTM products.
http://ift.tt/1qRsCex
http://ift.tt/1qRsCex
No comments:
Post a Comment